# Aquestive Therapeutics, Inc.: Form 8-K, filed Nov 4, 2024

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2024-11-04
- Accepted by EDGAR: Nov 4, 2024, 16:40 ET
- Period: 2024-11-04
- Accession: 0001628280-24-045028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024045028/aqst-20241104.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000162828024045028/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000162828024045028/aqst-20241104.htm

Filed Nov 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-045028. Last ingested by Listed: Nov 3, 2026, 19:40 ET. No prices; not investment advice.